Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, 4D Molecular Therapeutics Inc’s stock clocked out at $5.92, down -0.17% from its previous closing price of $5.93. In other words, the price has decreased by -$0.17 from its previous closing price. On the day, 2.1 million shares were traded.
Ratios:
To gain a deeper understanding of FDMT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.33 and its Current Ratio is at 17.33. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BMO Capital Markets on January 13, 2025, Downgraded its rating to Market Perform and sets its target price to $15 from $40 previously.
On November 21, 2024, Morgan Stanley started tracking the stock assigning a Underweight rating and target price of $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 16 ’24 when Bizily Scott sold 500 shares for $16.33 per share. The transaction valued at 8,165 led to the insider holds 6,781 shares of the business.
Bizily Scott sold 500 shares of FDMT for $7,500 on Aug 19 ’24. The Chief Legal Officer now owns 6,781 shares after completing the transaction at $15.00 per share. On Jul 16 ’24, another insider, Bizily Scott, who serves as the Chief Legal Officer of the company, sold 1,750 shares for $27.11 each. As a result, the insider received 47,442 and left with 6,781 shares of the company.
Stock Price History:
Over the past 52 weeks, FDMT has reached a high of $36.25, while it has fallen to a 52-week low of $4.43. The 50-Day Moving Average of the stock is -3.42%, while the 200-Day Moving Average is calculated to be -59.22%.
Shares Statistics:
A total of 52.00M shares are outstanding, with a floating share count of 38.13M. Insiders hold about 17.53% of the company’s shares, while institutions hold 97.40% stake in the company.
